327 related articles for article (PubMed ID: 8137344)
1. Pharmacokinetics and metabolism of vinca alkaloids.
Rahmani R; Zhou XJ
Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical pharmacology of vinca alkaloids.
Zhou XJ; Rahmani R
Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
[TBL] [Abstract][Full Text] [Related]
3. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
Zhou XJ; Placidi M; Rahmani R
Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
5. Human pharmacokinetics of a new Vinca alkaloid S 12363 with use of a monoclonal antibody-based radio- or enzyme immunoassay.
Lelievre E; Guillaudeux J; Cardona H; Bourguignat A; Lokiec F; Solere P; Lucas C; Sauveur C
Cancer Res; 1993 Aug; 53(15):3536-40. PubMed ID: 8339259
[TBL] [Abstract][Full Text] [Related]
6. [Vinca alkaloid and MDR1].
Takigawa N; Tanimoto M
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1086-9. PubMed ID: 18633246
[TBL] [Abstract][Full Text] [Related]
7. [Analytical limits in clinical pharmacokinetics: example of vinca-alkaloids].
Solere P; Lucas C
Bull Cancer; 1991; 78(9):775-87. PubMed ID: 1751829
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
Rahmani R; Bruno R; Iliadis A; Favre R; Just S; Barbet J; Cano JP
Cancer Res; 1987 Nov; 47(21):5796-9. PubMed ID: 3664483
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
[TBL] [Abstract][Full Text] [Related]
10. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
11. Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography.
van Tellingen O; Beijnen JH; Nooijen WJ; Bult A
Cancer Res; 1993 May; 53(9):2061-5. PubMed ID: 8481908
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
14. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
Kelly EB; Tuszynski JA; Klobukowski M
J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
[TBL] [Abstract][Full Text] [Related]
15. [Clinical pharmacokinetics of vinca alkaloids].
Rahmani R; Samak R; Bore P; Cano JP
Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
[TBL] [Abstract][Full Text] [Related]
16. Snail neurons as a possible model for testing neurotoxic side effects of antitumor agents: paracrystal formation by Vinca alkaloids.
Müller LJ; Moorer-van Delft CM; Roubos EW
Cancer Res; 1988 Dec; 48(24 Pt 1):7184-8. PubMed ID: 3191492
[TBL] [Abstract][Full Text] [Related]
17. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
18. Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid.
Schutz FA; Bellmunt J; Rosenberg JE; Choueiri TK
Expert Opin Drug Saf; 2011 Jul; 10(4):645-53. PubMed ID: 21524237
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems and combination therapy by using vinca alkaloids.
Lee CT; Huang YW; Yang CH; Huang KS
Curr Top Med Chem; 2015; 15(15):1491-500. PubMed ID: 25877096
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports.
Chan JD
Pharmacotherapy; 1998; 18(6):1304-7. PubMed ID: 9855331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]